Nazik Hammad

The Role of Maintenance Strategies in Metastatic Colorectal Cancer

Cancer treatment and survivorship statistics, 2022

Pancreatic cancer

Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies

The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma

Colorectal cancer

Biological roles of glycans

Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer

Measuring the multifaceted roles of mucin-domain glycoproteins in cancer

Systematic Meta-Analyses and Field Synopsis of Genetic Association Studies in Colorectal Cancer

Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma

Targeting autophagy in cancer

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

CA 19-9: Biochemical and Clinical Aspects

Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer

Chemotherapy for advanced gastric cancer

Expression of Tumour-Associated MUC1 Is a Poor Prognostic Marker in Breast Cancer in Kumasi, Ghana

An update on the management of breast cancer in Africa

Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis

Carbohydrate antigen 19‐9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine‐containing chemotherapy

CA19‐9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy

Continuous versus intermittent chemotherapy strategies in metastatic colorectal cancer: a systematic review and meta-analysis

A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers

Characterization of 9p24 Risk Locus and Colorectal Adenoma and Cancer: Gene–Environment Interaction and Meta-Analysis